This site is intended for health professionals only!

Published on 8 December 2011

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
EU takes the lead in shaping the future of biosimilars
Regeneron and Sanofi announce positive top line results from Phase III studies with sarilumab
Hospital pharmacy and ethics: what’s it all about?
Alert on Rocephin neonate risk
NICE limits degarelix treatment options

Botulinum toxin A: practice recommendations in France

teaser

Maryvonne Villart, Delphine Pozzi, Kamel Hamami

University Hospital

Raymond Poincar



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Liquid medicine measures
£45M in savings on offer to the NHS with Galen Trustsaver Collection
Exposure risks with cytotoxic drugs
Lundbeck and Solvay schizophrenia treatment put on hold
Warning over HIV drug combination